In vitro evaluation of the carcinogenic potential of perfluorinated chemicals
Article Sidebar
Main Article Content
Abstract
Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are the major components of long-chain per- and polyfluorinated alkyl substances (PFAS), known for their chemical stability and environmental persistence. Even if PFOA and PFOS have been phased out or are limited in use, they still represent a concern for human and environmental health. Several studies have been performed to highlight the toxicological behavior of these chemicals and their mode of action (MoA). Data suggested the causal association between PFOA or PFOS exposure and carcinogenicity in humans, but the outcomes of epidemiological studies showed some inconsistency. Moreover, the hypothesized MoA based on animal studies is considered not relevant for human cancer. In order to improve the knowledge on PFAS toxicology and contribute to the weight of evidence for the regulatory classification of PFAS, we used the BALB/c 3T3 cell transformation assay (CTA), an in vitro model under consideration to be included in an integrated approach to testing and assessment for non-genotoxic carcinogens (NGTxCs). PFOS and PFOA were tested at several concentrations by using a validated experimental protocol. Our results demonstrated that PFOA is not able to induce cell transformation, whereas PFOS exposure led to a concentration-related increase of type-III foci. Malignant foci formation is triggered at PFOS concentrations equal to or higher than 50 ppm. It is not directly associated with cytotoxicity or proliferation induction. The divergent CTA outcomes suggest that different molecular events could be responsible for the toxicological profiles of PFOS and PFOA, which were not completely captured in our study.
Plain language summary
This study explored PFOS and PFOA, common PFAS chemicals, to understand their potential harm and cancer risk. PFAS are known for their durability and resistance to heat, water and oil. They are persistent in the environment and may pose health risks despite decreased use. To better understand how PFOS and PFOA might be harmful, we conducted an in vitro test that can resemble the carcinogenesis process in experimental animals. Testing these chemicals on lab cells revealed PFOS can cause cancer-like changes, at levels of 50 parts per million or higher, but not PFOA. This difference suggests PFAS chemicals affect cells differently, but we need more research to understand exactly how they work and how they might cause cancer. Understanding this could help regulate and reduce PFAS harmful effects. Moreover, this research aligns with 3R principles by using cell-based tests as an alternative to animal testing, promoting ethical research practices.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Albrecht, P. P., Torsell, N. E., Krishnan, P. et al. (2013). A species difference in the peroxisome proliferator-activated receptor α-dependent response to the developmental effects of perfluorooctanoic acid. Toxicol Sci 131, 568-582. doi:10.1093/toxsci/kfs318
Alden, C. L., Lynn, A., Bourdeau, A. et al. (2011). A critical review of the effectiveness of rodent pharmaceutical carcinogenesis testing in predicting for human risk. Vet Pathol 48, 772-784. doi:10.1177/0300985811400445
Alexander, B. H. and Olsen, G. W. (2007). Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers. Ann Epidemiol 17, 471-478. doi:10.1016/j.annepidem.2007.01.036
Arrieta-Cortes, R., Farias, P., Hoyo-Vadillo, C. et al. (2017). Carcinogenic risk of emerging persistent organic pollutant perfluorooctane sulfonate (PFOS): A proposal of classification. Regul Toxicol Pharmacol 83, 66-80. doi:10.1016/j.yrtph.2016.11.021
ATSDR (2021) Toxicological Profile for Perfluoroalkyls, Released May 2021, Last Updated March 2020, Agency for Toxic Substances and Disease Registry
Barry, V., Winquist, A. and Steenland, K. (2013). Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121, 1313-1318. doi:10.1289/ehp.1306615
Beesoon, S. and Martin, J. W. (2015). Isomer-specific binding affinity of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) to serum proteins. Environ Sci Technol 49, 5722-5731. doi:10.1021/es505399w
Biegel, L. B., Hurtt, M. E., Frame, S. R. et al. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male cd rats. Toxicol Sci 60, 44-55. doi:10.1093/toxsci/60.1.44
Bilitewski, B., Darbra, R. M., Barceló, D. et al. (2013). Toxicological characterization of waste-related products using alternative methods: Three case studies. In (eds.), Global risk-based management of chemical additives ii. Springer Berlin Heidelberg. doi:10.1007/698_2012_176
Bischel, H. N., Macmanus-Spencer, L. A., Zhang, C. et al. (2011). Strong associations of short-chain perfluoroalkyl acids with serum albumin and investigation of binding mechanisms. Environ Toxicol Chem 30, 2423-2430. doi:10.1002/etc.647
Bonefeld-Jorgensen, E. C., Long, M., Bossi, R. et al. (2011). Perfluorinated compounds are related to breast cancer risk in greenlandic Inuit: A case control study. Environ Health 10, 88. doi:10.1186/1476-069X-10-88
Butenhoff, J. L., Chang, S. C., Olsen, G. W. et al. (2012a). Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in sprague dawley rats. Toxicology 293, 1-15. doi:10.1016/j.tox.2012.01.003
Butenhoff, J. L., Kennedy, G. L., Jr., Chang, S. C. et al. (2012b). Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in sprague-dawley rats. Toxicology 298, 1-13. doi:10.1016/j.tox.2012.04.001
Butenhoff, J. L., Pieterman, E., Ehresman, D. J. et al. (2012c). Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions. Toxicol Lett 210, 360-365. doi:10.1016/j.toxlet.2012.02.013
Callegaro, G., Stefanini, F. M., Colacci, A. et al. (2015). An improved classification of foci for carcinogenicity testing by statistical descriptors. Toxicol In Vitro 29, 1839-1850. doi:10.1016/j.tiv.2015.07.013
Caverly Rae, J. M., Frame, S. R., Kennedy, G. L. et al. (2014). Pathology review of proliferative lesions of the exocrine pancreas in two chronic feeding studies in rats with ammonium perfluorooctanoate. Toxicol Rep 1, 85-91. doi:10.1016/j.toxrep.2014.04.005
Chang, E. T., Adami, H. O., Boffetta, P. et al. (2014). A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans. Crit Rev Toxicol 44 Suppl 1, 1-81. doi:10.3109/10408444.2014.905767
Colacci, A., Mascolo, M. G., Perdichizzi, S. et al. (2011). Different sensitivity of BALB/c 3T3 cell clones in the response to carcinogens. Toxicol In Vitro 25, 1183-1190. doi:10.1016/j.tiv.2011.05.032
Colacci, A., Corvi, R., Ohmori, K. et al. (2023). The cell transformation assay: A historical assessment of current knowledge of applications in an integrated approach to testing and assessment for non-genotoxic carcinogens. Int J Mol Sci 24, doi:10.3390/ijms24065659
Corton, J. C., Peters, J. M. and Klaunig, J. E. (2018). The pparα-dependent rodent liver tumor response is not relevant to humans: Addressing misconceptions. Arch Toxicol 92, 83-119. doi:10.1007/s00204-017-2094-7
Crebelli, R., Caiola, S., Conti, L. et al. (2019). Can sustained exposure to pfas trigger a genotoxic response? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA. Regul Toxicol Pharmacol 106, 169-177. doi:10.1016/j.yrtph.2019.05.005
Dean, J. L., Zhao, Q. J., Lambert, J. C. et al. (2017). Editor's highlight: Application of gene set enrichment analysis for identification of chemically induced, biologically relevant transcriptomic networks and potential utilization in human health risk assessment. Toxicol Sci 157, 85-99. doi:10.1093/toxsci/kfx021
ECHA (2023). Restriction proposal on per- and polyfluoroalkyl substances (PFASs). Available at: https://echa.europa.eu/it/registry-of-restriction-intentions/-/dislist/details/0b0236e18663449b. march, 30.
EFSA (2018). Panel on contaminants in the food chain (CONTAM). Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA J 16, e05194. doi:10.2903/j.efsa.2018.5194
EPA (2016a). Health effects support document for perfluorooctanoic acid (PFOA). Available at https://www.epa.gov/sites/production/files/2016-05/documents/pfoa_hesd_final-plain.pdf
EPA (2016b). Health effects support document for perfluorooctane sulfonate (PFOS). Available at: https://www.epa.gov/sites/production/files/2016-05/documents/pfos_hesd_final_508.pdf March, 30.
EPA (2019). Epa’s per- and polyfluoroalkyl substances (PFAS) action plan. Epa 823r18004. Available at www.epa.gov/pfas.
Eriksen, K. T., Sorensen, M., McLaughlin, J. K. et al. (2009). Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general danish population. J Natl Cancer Inst 101, 605-609. doi:10.1093/jnci/djp041
EU (2006). Regulation (EC) no 1907/2006 of the European Parliament and of the Council of 18 december 2006 concerning the Registration, Evaluation, Authorisation and Restriction of chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) no 793/93 and Commission Regulation (EC) no 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/Eec, 93/67/EEC, 93/105/EC and 2000/21/EC.
EU (2008). Council Regulation (EC) no 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) no 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of chemicals (REACH).
EU (2022a). Commission Recommendation (EU) 2022/1431 of 24 August 2022 on the monitoring of perfluoroalkyl substances in food C/2022/5001 document 32022h1431. Available at http://data.europa.eu/eli/reco/2022/1431/oj.
EU (2022b). Commission Regulation (EU) 2022/2388 of 7 December 2022 amending Regulation (EC) no 1881/2006 as regards maximum levels of perfluoroalkyl substances in certain foodstuffs (text with EEA relevance) C/2022/8801 document 32022r2388. Available at: http://data.europa.eu/eli/reg/2022/2388/oj.
EU Chemical Strategy (2020). Communication from the Commission to the European Parliament, the Council, the European Economic and SOCIAL COMMITTEE and the committee of the regions chemicals strategy for sustainability towards a toxic-free environment. Available at: https://ec.europa.eu/environment/pdf/chemicals/2020/10/Strategy.pdf.
Frisbee, S. J., Brooks, A. P., Jr., Maher, A. et al. (2009). The C8 health project: Design, methods, and participants. Environ Health Perspect 117, 1873-1882. doi:10.1289/ehp.0800379
Frisbee, S. J., Shankar, A., Knox, S. S. et al. (2010). Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: Results from the C8 health project. Arch Pediatr Adolesc Med 164, 860-869. doi:10.1001/archpediatrics.2010.163
Gimenez-Bastida, J. A., Surma, M. and Zielinski, H. (2015). In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co. Toxicol In Vitro 29, 1683-1691. doi:10.1016/j.tiv.2015.07.001
Girardi, P. and Merler, E. (2019). A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid. Environ Res 179, 108743. doi:10.1016/j.envres.2019.108743
Gottmann, E., Kramer, S., Pfahringer, B. et al. (2001). Data quality in predictive toxicology: Reproducibility of rodent carcinogenicity experiments. Environ Health Perspect 109, 509-514. doi:10.1289/ehp.01109509
Grice, M. M., Alexander, B. H., Hoffbeck, R. et al. (2007). Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J Occup Environ Med 49, 722-729. doi:10.1097/JOM.0b013e3180582043
Hardell, E., Karrman, A., van Bavel, B. et al. (2014). Case-control study on perfluorinated alkyl acids (PFAAS) and the risk of prostate cancer. Environ Int 63, 35-39. doi:10.1016/j.envint.2013.10.005
IARC (2017). Working group on the evaluation of carcinogenic risks to humans. Some chemicals used as solvents and in polymer manufacture. Vol. Lyon, France: International Agency for Research on Cancer.
Ingelido, A. M., Marra, V., Abballe, A. et al. (2010). Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the italian general population. Chemosphere 80, 1125-1130. doi:10.1016/j.chemosphere.2010.06.025
Innes, K. E., Wimsatt, J. H., Frisbee, S. et al. (2014). Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large appalachian population. BMC Cancer 14, 45. doi:10.1186/1471-2407-14-45
Jacobs, M. N., Colacci, A., Louekari, K. et al. (2016). International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. ALTEX 33, 359-392. doi:10.14573/altex.1601201
Jacobs, M. N., Colacci, A., Corvi, R. et al. (2020). Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Arch Toxicol 94, 2899-2923. doi:10.1007/s00204-020-02784-5
Jacobs, M. N., Bult, J. M., Cavanagh, K. et al. (2023). OECD workshop consensus report: Ethical considerations with respect to human derived products, specifically human serum, in OECD test guidelines. Front Toxicol 5, 1140698. doi:10.3389/ftox.2023.1140698
Jacquet, N., Maire, M. A., Rast, C. et al. (2011). Perfluorooctanoic acid (PFOA) acts as a tumor promoter on Syrian Hamster Embryo (SHE) cells. Environ Sci Pollut Res Int 19, 2537-2549. doi:10.1007/s11356-012-0968-z
Jacquet, N., Maire, M. A., Landkocz, Y. et al. (2012). Carcinogenic potency of perfluorooctane sulfonate (PFOS) on Syrian Hamster Embryo (SHE) cells. Arch Toxicol 86, 305-314. doi:10.1007/s00204-011-0752-8
Judson, R. S., Houck, K. A., Kavlock, R. J. et al. (2010). In vitro screening of environmental chemicals for targeted testing prioritization: The Toxcast project. Environ Health Perspect 118, 485-492. doi:10.1289/ehp.0901392
Kaiser, A. M., Aro, R., Karrman, A. et al. (2021). Comparison of extraction methods for per- and polyfluoroalkyl substances (PFAS) in human serum and placenta samples-insights into extractable organic fluorine (EOF). Anal Bioanal Chem 413, 865-876. doi:10.1007/s00216-020-03041-5
Kato, K., Kalathil, A. A., Patel, A. M. et al. (2018). Per- and polyfluoroalkyl substances and fluorinated alternatives in urine and serum by on-line solid phase extraction-liquid chromatography-tandem mass spectrometry. Chemosphere 209, 338-345. doi:10.1016/j.chemosphere.2018.06.085
Kersten, S. and Stienstra, R. (2017). The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie 136, 75-84. doi:10.1016/j.biochi.2016.12.019
Knutsen, H. K., Alexander, J., Barregård, L. et al. (2018). EFSA panel on contaminants in the food chain: Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA journal 16, e05194. doi:10.2903/j.efsa.2018.5194
Lalloyer, F. and Staels, B. (2010). Fibrates, glitazones, and peroxisome proliferator–activated receptors. Arterioscler Thromb Vasc Biol 30, 894-9. doi:10.1161/ATVBAHA.108.179689
Lang, S., Loibl, M. and Herrmann, M. (2018). Platelet-rich plasma in tissue engineering: Hype and hope. Eur Surg Res 59, 265-275. doi:10.1159/000492415
Madia, F., Worth, A., Whelan, M. et al. (2019). Carcinogenicity assessment: Addressing the challenges of cancer and chemicals in the environment. Environ Int 128, 417-429. doi:10.1016/j.envint.2019.04.067
Mancini, F. R., Cano-Sancho, G., Gambaretti, J. et al. (2020). Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the french e3n cohort. Int J Cancer 146, 917-928. doi:10.1002/ijc.32357
Mascolo, M. G., Perdichizzi, S., Rotondo, F. et al. (2010). BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures. Toxicology in vitro 24, 1292-1300. doi:10.1016/j.tiv.2010.03.003
Mascolo, M. G., Perdichizzi, S., Vaccari, M. et al. (2018). The transformics assay: First steps for the development of an integrated approach to investigate the malignant cell transformation in vitro. Carcinogenesis 39, 955-967. doi:10.1093/carcin/bgy037
NTP (2023). NTP technical report on the toxicology and carcinogenesis studies of perfluorooctanoic acid (casrn 335-67-1) administered in feed to sprague dawley (hsd:Sprague dawley sd) rats (revised). National Toxicology Program. Technical Report 598 doi:10.22427/NTP-TR-598
OECD (2015). Guidance document on the in vitro Syrian Hamster Embryo (SHE) cell transformation assay. OECD Series on Testing and Assessment. Organization for Economic Co-operation and Development 214. https://www.oecd.org/env/ehs/testing/Guidance-Document-on-the-in-vitro-Syrian-Hamster-Embryo-Cell-Transformation-Assay.pdf
OECD (2017). Guidance document on the in vitro Bhas 42 cell transformation assay (Bhas 42 CTA). OECD Series on Testing and Assessment. Organisation for Economic Cooperation and Development. 231. https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV/JM/MONO(2016)1&doclanguage=en
OECD (2018a). Test no. 451: Carcinogenicity studies. OECD Guidelines for the Testing of Chemicals, Section 4. doi:10.1787/9789264071186-en.
OECD (2018b). Test no 453: Combined chronic toxicity/carcinogenicity studies. OECD Guidelines for the Testing of Chemicals, Section 4. doi:10.1787/9789264071223-en.
Paparella, M., Colacci, A. and Jacobs, M. N. (2017). Uncertainties of testing methods: What do we (want to) know about carcinogenicity? Altex 34, 235-252. doi:10.14573/altex.1608281
Pillo, G., Mascolo, M. G., Zanzi, C. et al. (2022). Mechanistic interrogation of cell transformation in vitro: The transformics assay as an exemplar of oncotransformation. Int J Mol Sci 23, doi:10.3390/ijms23147603
Pitter, G., Da Re, F., Canova, C. et al. (2020). Serum levels of perfluoroalkyl substances (PFAS) in adolescents and young adults exposed to contaminated drinking water in the Veneto region, italy: A cross-sectional study based on a health surveillance program. Environ Health Perspect 128, 27007. doi:10.1289/EHP5337
Raleigh, K. K., Alexander, B. H., Olsen, G. W. et al. (2014). Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occup Environ Med 71, 500-506. doi:10.1136/oemed-2014-102109
Ren, H., Vallanat, B., Nelson, D. M. et al. (2009). Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod Toxicol 27, 266-277. doi:10.1016/j.reprotox.2008.12.011
Ren, X. M., Zhang, Y. F., Guo, L. H. et al. (2015). Structure-activity relations in binding of perfluoroalkyl compounds to human thyroid hormone t3 receptor. Arch Toxicol 89, 233-242. doi:10.1007/s00204-014-1258-y
Rosen, M. B., Lee, J. S., Ren, H. et al. (2008). Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: Evidence for the involvement of nuclear receptors ppar alpha and car. Toxicol Sci 103, 46-56. doi:10.1093/toxsci/kfn025
Rosen, M. B., Das, K. P., Rooney, J. et al. (2017). Pparalpha-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling. Toxicology 387, 95-107. doi:10.1016/j.tox.2017.05.013
Rowan-Carroll, A., Reardon, A., Leingartner, K. et al. (2021). High-throughput transcriptomic analysis of human primary hepatocyte spheroids exposed to per- and polyfluoroalkyl substances as a platform for relative potency characterization. Toxicol Sci 181, 199-214. doi:10.1093/toxsci/kfab039
Sakai, A. (2007). BALB/c 3T3 cell transformation assays for the assessment of chemical carcinogenicity. AATEX 14, 367-373.
Sanchez Garcia, D., Sjodin, M., Hellstrandh, M. et al. (2018). Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - a comparison with lysosomotropic drugs. Chem Biol Interact 281, 1-10. doi:10.1016/j.cbi.2017.12.021
Sasaki, K., Bohnenberger, S., Hayashi, K. et al. (2012a). Recommended protocol for the BALB/c 3t3 cell transformation assay. Mutat Res 744, 30-35. doi:10.1016/j.mrgentox.2011.12.014
Sasaki, K., Bohnenberger, S., Hayashi, K. et al. (2012b). Photo catalogue for the classification of foci in the BALB/c 3T3 cell transformation assay. Mutat Res 744, 42-53. doi:10.1016/j.mrgentox.2012.01.009
Schrenk, D., Bignami, M., Bodin, L. et al. (2020). EFSA panel on contaminants in the food chain: Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA Journal 18, e06223. doi:10.2903/j.efsa.2020.622
Serra, S., Vaccari, M., Mascolo, M. G. et al. (2019). Hazard assessment of air pollutants: The transforming ability of complex pollutant mixtures in the Bhas 42 cell model. ALTEX 36, 623-633. doi:10.14573/altex.1812173
Shearer, J. J., Callahan, C. L., Calafat, A. M. et al. (2021). Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. J Natl Cancer Inst 113, 580-587. doi:10.1093/jnci/djaa143
Sonich-Mullin, C., Fielder, R., Wiltse, J. et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34, 146-152. doi:10.1006/rtph.2001.1493
Sonnenberg, N. K., Ojewole, A. E., Ojewole, C. O. et al. (2023). Trends in serum per- and polyfluoroalkyl substance (pfas) concentrations in teenagers and adults, 1999-2018 nhanes. Int J Environ Res Public Health 20, doi:10.3390/ijerph20216984
Steenland, K., Fletcher, T. and Savitz, D. A. (2010). Epidemiologic evidence on the health effects of perfluorooctanoic acid (pfoa). Environ Health Perspect 118, 1100-1108. doi:10.1289/ehp.0901827
Steenland, K. and Woskie, S. (2012). Cohort mortality study of workers exposed to perfluorooctanoic acid. Am J Epidemiol 176, 909-917. doi:10.1093/aje/kws171
Steenland, K., Fletcher, T., Stein, C. R. et al. (2020). Review: Evolution of evidence on pfoa and health following the assessments of the c8 science panel. Environ Int 145, 106125. doi:10.1016/j.envint.2020.106125
Steenland, K. and Winquist, A. (2021). PFAS and cancer, a scoping review of the epidemiologic evidence. Environ Res 194, 110690. doi:10.1016/j.envres.2020.110690
Stockholm Convention (2009). The new pops under the stockholm convention, SC-4/17: Listing of perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl fluoride. Available at: https://www.pops.int/Portals/0/download.aspx?d=UNEP-POPS-COP.4-SC-4-17.English.pdf
Stockholm Convention (2019). The new pops under the Stockholm Convention, SC-9/12: Listing of perfluorooctanoic acid (PFOA), its salts and PFOA-related compounds. Available at: https://www.pops.int/Portals/0/download.aspx?d=UNEP-POPS-COP.9-SC-9-12.English.pdf
Subbiahanadar Chelladurai, K., Selvan Christyraj, J. D., Rajagopalan, K. et al. (2021). Alternative to FBS in animal cell culture - An overview and future perspective. Heliyon 7, e07686. doi:10.1016/j.heliyon.2021.e07686
Temkin, A. M., Hocevar, B. A., Andrews, D. Q. et al. (2020). Application of the key characteristics of carcinogens to per and polyfluoroalkyl substances. Int J Environ Res Public Health 17, 1668. doi:10.3390/ijerph17051668
Tsai, M. S., Chang, S. H., Kuo, W. H. et al. (2020). A case-control study of perfluoroalkyl substances and the risk of breast cancer in taiwanese women. Environ Int 142, 105850. doi:10.1016/j.envint.2020.105850
Tsuda, S. (2016). Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). J Toxicol Sci 41, SP27-SP36. doi:10.2131/jts.41.SP27
Vanden Heuvel, J. P., Thompson, J. T., Frame, S. R. et al. (2006). Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: A comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver x receptor-beta, and retinoid x receptor-alpha. Toxicol Sci 92, 476-489. doi:10.1093/toxsci/kfl014
Verma, A., Verma, M., Singh, A. (2020). Animal tissue culture principles and applications. Animal Biotechnology 2020, 269–93. doi:10.1016/B978-0-12-811710-1.00012-4
Vieira, V., Hoffman, K. and Fletcher, T. (2013). Assessing the spatial distribution of perfluorooctanoic acid exposure via public drinking water pipes using geographic information systems. Environ Health Toxicol 28, e2013009. doi:10.5620/eht.2013.28.e2013009
Wan, H. T., Zhao, Y. G., Wei, X. et al. (2012). Pfos-induced hepatic steatosis, the mechanistic actions on beta-oxidation and lipid transport. Biochim Biophys Acta 1820, 1092-1101. doi:10.1016/j.bbagen.2012.03.010
Wang, J., Hallinger, D. R., Murr, A. S. et al. (2019). High-throughput screening and chemotype-enrichment analysis of toxcast phase ii chemicals evaluated for human sodium-iodide symporter (nis) inhibition. Environ Int 126, 377-386. doi:10.1016/j.envint.2019.02.024
Wang, Y., Zhang, H., Kang, Y. et al. (2016). Effects of perfluorooctane sulfonate on the conformation and activity of bovine serum albumin. J Photochem Photobiol B 159, 66-73. doi:10.1016/j.jphotobiol.2016.03.024
Woutersen, M., Beekman, M., Pronk, M. et al. (2018). Does REACH provide sufficient information to regulate mutagenic and carcinogenic substances. Human and Ecological Risk Assessment: An International Journal, 25(8), 1996–2016. doi:10.1080/10807039.2018.1480351
Yang, Q., Nagano, T., Shah, Y. et al. (2008). The PPARα-humanized mouse: A model to investigate species differences in liver toxicity mediated by PPARα. Toxicol Sci 101, 132-139. doi:10.1093/toxsci/kfm206
Zahm, S., Bonde, J. P., Chiu, W. A. et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol 25, 16-17. doi:10.1016/S1470-2045(23)00622-8
Zeng, Z., Song, B., Xiao, R. et al. (2019). Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies. Environ Int 126, 598-610. doi:10.1016/j.envint.2019.03.002
Zhang, L., Ren, X. M., Wan, B. et al. (2014). Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor gamma. Toxicol Appl Pharmacol 279, 275-283. doi:10.1016/j.taap.2014.06.020
Zhang, Y. M., Dong, X. Y., Fan, L. J. et al. (2017). Poly- and perfluorinated compounds activate human pregnane x receptor. Toxicology 380, 23-29. doi:10.1016/j.tox.2017.01.012